Journal
PAEDIATRIC RESPIRATORY REVIEWS
Volume 35, Issue -, Pages 43-49Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.prrv.2020.06.010
Keywords
Covid 19; Vaccines; Human trials; Timeline
Categories
Funding
- National Health and Medical Research Council [GNT1145817]
Ask authors/readers for more resources
There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 - the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead. (C) 2020 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available